Personalized T-cell therapy for advanced gastrointestinal cancer
Part of Cancer, Digestive system clinical trials.
This trial tests a new type of cell therapy using your own immune cells (T-cells) that are specially trained to attack your cancer. It is for people with advanced gastrointestinal cancers like esophageal, stomach, or colon cancer that have not responded to other treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have advanced gastrointestinal cancer (like esophageal, stomach, or colon cancer) that has not responded to or has come back after at least one prior treatment.
- You can provide a fresh tumor sample (from a biopsy or surgery) and have blood cells collected through a procedure called apheresis.
- You have at least one tumor that can be measured on a CT or MRI scan.
- You are in reasonably good health: able to care for yourself and perform daily activities, and your organ function (like kidney, liver, and blood counts) meets the study's requirements.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new type of cell therapy (BGT007H cells) for people with advanced gastrointestinal cancers that have not responded to at least two standard treatments. The therapy uses your own immune cells that are modified to target and attack the cancer.
This trial tests an immunotherapy that uses your own immune cells to fight advanced digestive-system cancers. It aims to see if this treatment is safe and if it can help shrink tumors or slow their growth.
This trial tests a new cell therapy called BGT007 for people with advanced cancers of the digestive system (esophagus, stomach, pancreas, or colon) that have not responded to standard treatments. The therapy uses your own immune cells, modified to target a protein on your cancer cells.
This study tests a new treatment using your body's own immune cells (called tumor-infiltrating lymphocytes) that are taken from your tumor, grown in a lab, and then put back into you. It's for people with advanced solid tumors who have run out of standard options.
This early-phase trial tests a new type of immune cell therapy (TCRx T cells) for advanced stomach cancer that has not responded to standard chemotherapy. The goal is to see if these specially engineered cells can help your body fight the cancer.
This trial tests a custom-made T-cell treatment designed to target unique markers on your tumor. It's for people with advanced colorectal cancer who have run out of standard options or can't take them, and it aims to shrink tumors and improve survival.
Hear when a new Advanced Gastrointestinal Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.